Literature DB >> 15902953

The symptoms, neurobiology, and current pharmacological treatment of depression.

Stephen E To1, Robert A Zepf, Alisa G Woods.   

Abstract

Depression as a medical disorder increasingly is being recognized and treated. The mood of an individual with major depression is often described as sad, hopeless, or discouraged, and there are many physical symptoms associated with depression. Pharmacologic treatments for depression have advanced greatly since the development of the first therapies, monoamine oxidase inhibitors (MAOIs). Many medications, such as tricyclic antidepressants (TCAs), selective serotonin reuptake inhibitors (SSRIs), and serotonin norepinephrine reuptake inhibitors (SNRIs), currently are available to help combat this health problem. Newer medications have eliminated many of the side effects associated with older therapies, and treatments in development are designed with the goal of further improving on efficacy while eliminating side effects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902953

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  6 in total

1.  The effect of sympathetic antagonists on the antidepressant action of alprazolam.

Authors:  Ra Al-Tubuly; Sm Aburawi; Ea Alghzewi; Zm Gorash; S Errwami
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

Review 2.  The potential of biomarkers in psychiatry: focus on proteomics.

Authors:  Izabela Sokolowska; Armand G Ngounou Wetie; Kelly Wormwood; Johannes Thome; Costel C Darie; Alisa G Woods
Journal:  J Neural Transm (Vienna)       Date:  2013-12-20       Impact factor: 3.575

3.  Occurrence and risk assessment of antidepressants in Huangpu River of Shanghai, China.

Authors:  Minghong Wu; Jiajia Xiang; Fenfen Chen; Cao Fu; Gang Xu
Journal:  Environ Sci Pollut Res Int       Date:  2017-07-13       Impact factor: 4.223

4.  Resveratrol inhibits nicotinic stimulation-evoked catecholamine release from the adrenal medulla.

Authors:  Seong-Chang Woo; Gwang-Moon Na; Dong-Yoon Lim
Journal:  Korean J Physiol Pharmacol       Date:  2008-08-31       Impact factor: 2.016

Review 5.  Psychiatric disorders biochemical pathways unraveled by human brain proteomics.

Authors:  Verônica M Saia-Cereda; Juliana S Cassoli; Daniel Martins-de-Souza; Juliana M Nascimento
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-07-04       Impact factor: 5.270

Review 6.  Depression in pulmonary arterial hypertension and interstitial lung diseases.

Authors:  Sameer Verma; Jose Cardenas-Garcia; Prasanta R Mohapatra; Arunabh Talwar
Journal:  N Am J Med Sci       Date:  2014-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.